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The majority of in vitro-grown Neisseria gonorrhoeae strains were unable to use hemoglobin as the sole source
of iron for growth (Hgb2), but a minor population was able to do so (Hgb1). The ability of Hgb1 gonococci to
utilize hemoglobin as the iron source was associated with the expression of an iron-repressible 89-kDa hemo-
globin-binding protein in the outer membrane. The N-terminal amino acid sequence of this protein revealed
amino acids, from positions 2 to 16, identical to those of HpuB, an 85 kDa iron-regulated hemoglobin-hapto-
globin utilization outer membrane protein of Neisseria meningitidis. Isogenic mutants constructed by allelic
replacement with a meningococcal hpu::mini-Tn3erm construct no longer expressed the 89-kDa protein.
Mutants could not utilize hemoglobin to support growth but still grew on heme. Thus, the gonococcal HpuB
homolog is a functional hemoglobin receptor and is essential for growth with hemoglobin.
In mammalian hosts, the amount of free iron available to
invading bacterial pathogens is usually less than that required
for growth because of the presence of iron-binding proteins
and iron-containing compounds (41). The majority of iron is
sequestered in erythrocyte hemoglobin, which represents an
important iron source for bacteria (33). Access to the iron in
erythrocytes requires lysis, often mediated by hemolysins, and
the release of hemoglobin and heme. However, hemoglobin
released from the lysis of erythrocytes is bound by the serum
protein haptoglobin (3). Heme is bound by the serum proteins
hemopexin and albumin (31). Iron is bound by the iron-binding
proteins transferrin and lactoferrin (5, 9). Thus, there is little
or no free hemoglobin, heme, or iron under normal physiolog-
ical conditions in the hosts.
Several pathogenic organisms have developed specific mech-
anisms for iron acquisition which are inducible under iron-
limited growth conditions. The genital mucosal pathogen Neis-
seria gonorrhoeae is known to use iron from lactoferrin and
transferrin for growth (29, 30). The ability to use lactoferrin
and transferrin is due to specific receptors (reviewed in refer-
ence 9). Gonococci are also able to utilize heme and certain
heme-containing proteins as iron sources (12, 30). Two heme-
binding proteins (with sizes of 99 and 44 kDa) have been
isolated from the total membranes of gonococcal clinical iso-
lates grown under iron-limited conditions (20). Nevertheless,
the mechanism of iron uptake from these compounds is un-
clear.
Using a biotinylated human hemoglobin probe in a dot bind-
ing assay, Lee and Hill (23) detected hemoglobin-binding ac-
tivity from meningococci grown under iron-limited conditions.
More recently, two different meningococcal hemoglobin recep-
tors have been described. Stojiljkovic et al. (37) cloned a gene
(hmbR) encoding an 89.5-kDa outer membrane protein (HmbR)
which shares amino acid similarity with the family of TonB-
dependent membrane receptors. Lewis and Dyer (24) de-
scribed Hpu, an 85-kDa iron-repressible outer membrane
protein responsible for the utilization of hemoglobin or hemo-
globin-haptoglobin complexes as an iron source. This protein
has since been renamed HpuB to distinguish it from a second
genetically linked protein, HpuA (25). Another hemoglobin-
binding outer membrane protein (HgbA) was identified in
Haemophilus ducreyi by Elkins (13). Expression of this 100-kDa
protein was regulated by the level of heme but not of iron
present in the medium. The deduced protein sequence of the
cloned hgbA gene is also similar to those of the TonB-depen-
dent outer membrane receptors (14). Considerable similarity
exists between the amino acid sequence of HgbA and that of
HmbR (14, 37).
Mickelsen and Sparling (30) showed that 18 of 29 gonococ-
cal strains studied were capable of using hemoglobin for
growth. In a previous study, Dyer et al. (12) found that gono-
coccal strain FA19 did not grow appreciably with hemoglobin,
whereas strain F62 grew well with both hemoglobin and he-
moglobin-haptoglobin complexes. Binding of hemoglobin to
haptoglobin did not affect the inability of FA19 to grow with
hemoglobin (12). However, we recently observed that FA19
generated rare colonies which grew on modified gonococcal
medium base agar plates containing hemoglobin and the iron
chelator Desferal (deferoxamine mesylate; CIBA Pharmaceu-
tical Co.) instead of the regular iron supplement, ferric nitrate.
Subculture of these hemoglobin-utilizing colonies yielded lux-
uriant growth on hemoglobin-Desferal plates. Thus, these
FA19 isolates were variants expressing a different hemoglobin-
utilizing phenotype. We designated gonococci able to grow on
hemoglobin-Desferal plates as Hgb1 and those unable to grow
on hemoglobin-Desferal plates as Hgb2.
The objectives of this study were to enumerate the apparent
phase-varying phenomenon of hemoglobin utilization inN. gonor-
rhoeae strains and to identify and purify the outer membrane
protein responsible for the utilization of hemoglobin as the
sole source of iron.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacteria used in this study were
five N. gonorrhoeae strains routinely maintained in our laboratory (FA19,
FA1090, MS11, F62, and PGH3.2) and five recent clinical isolates (FA6940,
FA6941, FA6942, FA6943, and FA6944) kindly provided to us from the labora-
tory of Myron Cohen (Department of Medicine, the University of North Caro-* Corresponding author.
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lina at Chapel Hill) (Table 1). Two mutants of FA19, FA6783, a transferrin
receptor and lactoferrin receptor double mutant (TF2/LF2) (5), and FA6807, an
iron-regulated protein B mutant (FrpB2) (2), and one meningococcal strain,
FAM69 (39), were also used. These organisms were routinely cultivated at 368C
in a 5% CO2 atmosphere on Bacto GC medium base (Difco) containing
Kellogg’s supplement I (19) and ferric nitrate [Fe(NO3)3] at 12 mM (GCB
plates). Liquid cultures were grown in broth containing the same components as
those for the GC medium base and supplements but without Bacto agar. The
Hgb1 variants were grown on modified GCB plates containing human hemo-
globin (Sigma), Kellogg’s supplement I, and the iron chelator Desferal at a final
concentration of 50 mM (Hg-Desferal plates). Hemoglobin stock solution was
prepared by dissolving 200 mg of hemoglobin in 10 ml of phosphate-buffered
saline (PBS) and mixing at room temperature for 3 to 4 h. The stock solution was
then filtered through a 0.45-mm-pore-size Sterile Acrodisc (Gelman Sciences).
The entire filtrate at a protein concentration of 10 to 12 mg/ml was used in 1-liter
Hg-Desferal plates. For antibiotic selection erythromycin at 1 mg/liter was used
for mini-Tn3erm (39).
Determination of variation rate from Hgb2 to Hgb1.Gonococcal hemoglobin-
utilizing variants were first identified by streaking a single wild-type colony from
a GCB plate to an Hg-Desferal plate and selecting for surviving colonies. The
frequency of reversion from the non-hemoglobin-utilizing phenotype (Hgb2) to
the hemoglobin-utilizing phenotype (Hgb1) was calculated from the relative
numbers of colonies growing on regular GCB plates and Hg-Desferal plates.
GCB plate-grown Hgb2 gonococcal cells were suspended in GC medium broth
to an optical density at 600 nm of 0.2 (approximately 2 3 108 CFU/ml). One
hundred microliters of a 1023 dilution was plated on an Hg-Desferal plate, and
100 ml of a 1025 dilution was plated on a GCB plate. Colonies were counted after
24 h.
Preparations of whole-cell dot blots and outer membranes from gonococci
grown under iron-replete and iron-starved conditions. Gonococci were grown in
iron-sufficient and iron-starved media. Gonococcal medium broth containing
Kellogg’s supplement I was inoculated from overnight, plate-grown gonococcal
cultures (Hgb2 on GCB plates and Hgb1 on Hg-Desferal plates). After one mass
doubling, cultures were split. Desferal was added to 50 mM to induce iron
starvation in one flask, whereas supplement II (ferric nitrate [12 mM]) was added
to the other flask. After 4 h of growth with either the chelator or the iron
supplement, cells were harvested by centrifugation. The density of harvested cells
was adjusted to an optical density at 600 nm of 0.2 with PBS. Dot blots consisted
of wells loaded with 100 ml of the adjusted cell suspensions. Outer membranes
were prepared by the procedure used by Elkins (13). The protein content was
determined by a bicinchoninic acid assay (Pierce) after the outer membrane
pellet was resuspended in 10 mM HEPES [4-(2-hydroxyethyl)-1-piperazine-eth-
anesulfonic acid] (pH 7.4).
Purification of hemoglobin-binding protein. Purification of the hemoglobin-
binding protein employed both bovine hemoglobin-agarose (chromatography
specialty resin) supplied by Sigma and human hemoglobin-agarose prepared in
our laboratory. Human hemoglobin (Sigma) was coupled to Affi-Gel 15 (Bio-
Rad) according to the manufacturer’s instructions. Unbound hemoglobin was
removed by washing with Tris-buffered saline (0.5 M Tris-HCl, 1.5 M NaCl [pH
7.5]). Purification with solid-phase hemoglobin-agarose was done according to a
procedure described by Elkins (13). The hemoglobin-binding protein was eluted
in Laemmli sample buffer for analytical sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and Western blotting (immunoblotting).
N-terminal amino acid sequence determination, peptide synthesis, and im-
munization. For N-terminal amino acid analysis, a hemoglobin affinity-purified
protein of an FA19 Hgb1 variant was electrophoresed by SDS-PAGE and
electroblotted to a polyvinylidene difluoride filter (Bio-Rad). The 89-kDa pro-
tein was located by Ponceau S staining (Sigma). The N-terminal amino acid
sequence was analyzed by the UNC/PMBB MicroProtein Chemistry Facility
(Program in Molecular Biology and Biotechnology at the University of North
Carolina at Chapel Hill) with a Perkin Elmer/ABI Procise model 491 protein/
peptide sequencer. Peptide synthesis was performed at the same facility with a
multiple peptide synthesizer (Rainin Symphony) following the procedure de-
scribed by Elkins (13). The synthetic peptide was analyzed by time-of-flight mass
spectrometry to ensure that the molecular weight of the product was correct.
Two female rabbits were immunized four times with the synthetic N-terminal
peptide coupled to Keyhole limpet hemocyanin (Pierce) in Freund’s adjuvant.
Three hundred microgram of peptide per rabbit was injected intradermally at 0
week with complete Freund’s adjuvant. The rabbits were then boosted at 2, 4,
and 6 weeks with incomplete Freund’s adjuvant and bled at week 10.
Insertional mutagenesis of gene encoding the 89-kDa protein. Lewis and Dyer
(24) constructed two plasmids, pSM85k and pSM85kE. The pSM85k contains an
850-bp hpuB insert originally identified from the genomic library of Neisseria
meningitidis FAM70 (24, 39) with an oligonucleotide probe designed on the basis
of the N terminus of HpuB. Shuttle mutagenesis (35) of pSM85k, with mini-
Tn3erm (39) as the transposon, resulted in a derivative, pSM85kE, containing
mTn3erm in the 850-bp insert. Uncut pSM85kE DNA was then transformed (4)
into gonococcal strains FA19 Hgb1 and FA1090 Hgb1. The transformant col-
onies were screened for resistance to erythromycin at 1 mg/liter and the inability
to grow on hemoglobin-Desferal plates.
DNA hybridization. For Southern blot analysis, chromosomal DNAs from
FA19 Hgb1, FA1090 Hgb1, and the respective transposon mutants were di-
gested with ClaI and fractionated on 0.7% agarose gels. Gels were transferred
bidirectionally to Magnagraph nylon (Micron Separations). The blots were
probed, as described in Results, with random-primed digoxigenin-dUTP-labeled
DNA and developed according to the Genius labeling and detection instructions
(Boehringer-Mannheim Biochemicals).
Dot blot assay for haptoglobin content of human hemoglobin. Dot blots were
prepared with 10-fold serial dilutions of human haptoglobin (Sigma), starting at
1 mg per well. Ten-fold serial dilutions of human hemoglobin (Sigma), starting at
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant phenotype Reference
Strains
Gonococcal Lab strains
FA19 Wild type 30
FA1090 Wild type 32
MS11 Wild type 28
F62 Wild type 19
PGH3.2 Wild type 7
FA6783 FA19 TF2/LF2 mutant 5
FA6807 FA19 FrpB2 mutant 2
FA6930 FA19 Hgb2 mutant (hpu::mTn3erm) This study
FA6929 FA1090 Hgb2 mutant (hpu::mTn3erm) This study
Recent clinical isolates
FA6940 Wild type Laboratory of Myron Cohen
FA6941 Wild type Laboratory of Myron Cohen
FA6942 Wild type Laboratory of Myron Cohen
FA6943 Wild type Laboratory of Myron Cohen
FA6944 Wild type Laboratory of Myron Cohen
Meningococcal strain FAM69 HpuB1 39
Plasmids
pSM85k 850-bp ApoI fragment of hpu in pHSS8 24
pSM85kE pSM85k::mTn3erm 24
pIRS756 hmbR from IR1113 (MS11 gene) 38
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10 mg per well, were also prepared. These blood proteins were immobilized onto
nitrocellulose membrane by vacuum filtration. Duplicate dot blot strips were
probed with anti-human haptoglobin antibodies; a monoclonal antibody specific
for the three haplotypes found in normal plasma, 1-1, 2-1, and 2-2 (Sigma
H6395), at 1:4,000 dilution; or a polyclonal antibody raised in goat (Sigma
H5015), at 1:2,000. The secondary reagents used were either goat anti-mouse
immunoglobulin G-alkaline phosphatase conjugate (Bio-Rad) or anti-goat im-
munoglobulin G-alkaline phosphatase conjugate (Sigma). Colorimetric detec-
tion of the binding followed the procedure described in the Genius System user’s
guide (Boehringer-Mannheim Biochemicals).
Whole-cell dot blot hemoglobin binding assay and outer membrane Western
blot analysis. Three gonococcal Hgb1 variants and mTn3erm insertional mu-
tants of FA19 Hgb1 and FA1090 Hgb1 were examined for their ability to bind
hemoglobin in a dot blot assay. Human hemoglobin was biotinylated with sul-
fosuccinimidyl 2-(biotinamido) ethyl-1,3-dithiopropionate (NHS-SS-Biotin;
Pierce). The unbound biotin was removed by dialysis overnight in PBS at 48C.
The binding was detected by colorimetric detection with alkaline phosphatase-
conjugated streptavidin (Pierce) as the secondary reagent. SDS-PAGE and
Western blotting of outer membrane proteins were performed as described by
Harlow and Lane (17).
Iron-dependent growth. In order to examine growth with specific iron sources,
FA19 Hgb2 and Hgb1 variants and the hpuB insertional mutant FA6930 were
iron starved in Chelex-treated medium (CDM) and then grown in liquid cultures
supplemented with the iron source of interest. Gonococci were grown overnight
on CDM agar containing 5 mM ferric nitrate (12) and then suspended in CDM
to approximately 15 Klett units. Each culture was incubated with shaking at 378C
in a 5% CO2 atmosphere for 2 h and then divided into five subcultures by
dilution with fresh CDM. These subcultures were supplemented with various
iron sources and incubated for 8 more h. Ferric nitrate was used at a concen-
tration of 100 mM. Human hemoglobin was used at a final concentration of 0.5
mM, and human haptoglobin was used at a final concentration of 1.0 mM.
Hemoglobin-haptoglobin complexes were prepared by gentle mixing of these two
compounds at respective concentrations of 0.5 and 1.0 mM at room temperature
for 1 h before use. Desferal at the concentration of 50 mM was added to cultures
supplemented with hemoglobin, haptoglobin, hemoglobin-haptoglobin com-
plexes, and a no-iron control.
RESULTS
Variation rate from Hgb2 to Hgb1. Screening of five labo-
ratory strains and five clinical isolates of N. gonorrhoeae dem-
onstrated that the ability to use hemoglobin as a sole iron
source for in vitro growth was a highly variable trait in all
tested strains. None of these tested strains grew well on Hg-
Desferal plates, when hemoglobin was the sole usable source
of iron. However, each strain gave rise to variants that grew
very well on the same medium. The rate of variation from
Hgb2 to Hgb1 was as high as 1:465 in FA6943 and as low as
1:12,500 in FA6941 (Table 2). It was not possible to test for the
frequency of variation from Hgb1 to Hgb2, because of the lack
of a selectable phenotype for inability to utilize hemoglobin.
Nevertheless, the high frequency of the one-directional varia-
tion (Hgb2 to Hgb1) suggested that the ability to use hemo-
globin might be a phase-variable event.
Identification of hemoglobin-binding protein. We hypothe-
sized that the Hgb1 variants of N. gonorrhoeae expressed he-
moglobin and/or heme receptors in order to be able to utilize
hemoglobin as the sole source of iron. To determine if the
Hgb1 variant of FA19 expressed an iron-regulated, hemoglo-
bin-binding outer membrane protein, outer membranes were
prepared from cells grown in both iron-sufficient and iron-
limited media. Solubilized outer membranes were then sub-
jected to affinity purification with immobilized hemoglobin.
The Coomassie blue-stained SDS-PAGE gel of outer mem-
branes and purified proteins revealed an iron-repressible 89-
kDa protein (Fig. 1, compare lanes 1 and 2) which bound to
bovine hemoglobin-agarose (Fig. 1, compare lanes 4 and 5).
This novel protein was also present in the Hgb1 variant of
FA6783, a TF2/LF2 mutant of FA19 (Fig. 1, lanes 3 and 6),
indicating that this protein was not a breakdown product of
Tbp1 or Lbp1.
Further identification and purification of the 89-kDa hemo-
globin-binding protein. Additional outer membrane prepara-
tions further revealed that the 89-kDa protein was not ex-
pressed in iron-stressed FA19 Hgb2 (Fig. 2, lane 3) but was
expressed in membranes prepared from iron-stressed Hgb1
variants of FA6807, an FrpB2 mutant of FA19 (Fig. 2, lane
11). Expression of this protein in the FrpB2 mutant suggested
that the expression was not contingent on the expression of
FIG. 1. SDS-PAGE analysis of outer membrane proteins (lanes 1 to 3) and
proteins recovered from bovine hemoglobin-agarose-affinity purification (lanes 4
to 6). Proteins were stained with Coomassie blue. Lanes: 1 and 4, iron-replete
(Fe1) FA19 Hgb1 variant; 2 and 5, iron-starved (Fe2) FA19 Hgb1; 3 and 6,
iron-starved FA6783 Hgb1; MW STD, molecular weight standards (with weights
in thousands indicated on the left).
FIG. 2. SDS-PAGE analysis of outer membrane proteins (odd-numbered
lanes) and proteins recovered from human hemoglobin-agarose-affinity purifica-
tion (even-numbered lanes). Proteins were stained with Coomassie blue. Lanes:
1 and 2, FA19 Hgb2 Fe1; 3 and 4, FA19 Hgb2 Fe2; 5 and 6, FA19 Hgb1 Fe1;
7 and 8, FA19 Hgb1 Fe2; 9 and 10, FA6783 Hgb1 Fe2; 11 and 12, FA6807 Hgb1
Fe2; 13 and 14, FA6930 Fe2; 15 and 16, FA1090 Hgb1 Fe2; MW STD, molec-
ular weight standards (with weights in thousands indicated on the left). An
asterisk is placed next to the 89-kDa protein between the outer membrane
protein lane and the purified protein lane. Fe1 and Fe2 refer to growth in
abundant iron or in iron starvation, respectively.
TABLE 2. Variation rate in occurrence of Hgb2 to Hgb1
Strain No. of variants/1,000 CFUa
FA19 ....................................................................................... 1.00 6 0.12
FA1090 ................................................................................... 1.36 6 0.49
MS11 ....................................................................................... 0.25 6 0.06
F62 .......................................................................................... 0.94 6 0.38
PGH3.2 ................................................................................... 0.31 6 0.11
FA6940 ................................................................................... 1.06 6 0.07
FA6941 ................................................................................... 0.08 6 0.01
FA6942 ................................................................................... 0.12 6 0.06
FA6943 ................................................................................... 2.15 6 0.24
FA6944 ................................................................................... 1.32 6 0.38
a The values are the averages 6 standard deviations for three experiments.
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FrpB. The 89-kDa protein was also identified in the iron-
stressed Hgb1 variant of FA1090 (Fig. 2, lane 15).
Purification with bovine hemoglobin-agarose resulted in rel-
atively pure preparations of the 89-kDa protein (Fig. 1). How-
ever, for the purpose of showing a more relevant ligand, hu-
man hemoglobin-agarose prepared in our laboratory was used
in later affinity purifications. When solubilized outer mem-
branes prepared from the iron-starved Hgb1 variants of FA19,
FA6783, FA6807, and FA1090, were subjected to human he-
moglobin-agarose, two other proteins appeared in the elution
along with the 89-kDa protein (Fig. 2, lanes 8, 10, 12, and 16).
One band appeared at about 100 kDa (Fig. 2, lanes 4, 8, 12, 14,
and 16) and the other appeared at about 70 kDa (Fig. 2, lanes
2, 4, 6, 8, 12, 14, and 16). The iron-repressible 100-kDa band
was not found in the iron-starved Hgb1 variant of FA6783
(Fig. 2, lane 10), a mutant which could not express Tbp1 and
Lbp1. The 70-kDa band was not iron-regulated (Fig. 2, lanes 2
and 6). For most membrane preparations, it appeared only
after repeated heating of membrane proteins in Laemmli sam-
ple buffer (Fig. 2, lanes 10 and 14). This protein band was
present in proteins purified from the outer membranes of
FA6807 Hgb1, a mutant which could not express the iron-
regulated FrpB (Fig. 2, lane 12).
N-terminal amino acid sequence of hemoglobin-binding pro-
tein. The N-terminal amino acid sequence of the gel-purified
89-kDa protein from the iron-stressed FA19 Hgb1 variant was
determined by Edman degradation. The amino acids at posi-
tions 2 to 24 were DPAPQSAQTLNEITVTGTHKTQK. The
amino acids at positions 2 to 16 were identical to those of
HpuB, an 85-kDa iron-regulated hemoglobin-haptoglobin uti-
lization protein identified in the outer membrane of N. men-
ingitidis (24).
Insertional inactivation of the gene encoding the hemoglo-
bin-binding protein. Transformation of meningococcal strain
DNM2 with pSM85kE, a plasmid containing mTn3erm in-
serted within the 850-bp hpuB fragment, resulted in a mutant
which was impaired in the utilization of free hemoglobin and
hemoglobin-haptoglobin complexes to support growth (24).
We used the same plasmid in the transformation of gonococcal
Hgb1 variants and obtained erythromycin-resistant mutants of
FA19 (FA6930) and FA1090 (FA6929). These mutants could
not grow on Hg-Desferal plates (data not shown) but could use
heme as a source of iron for growth (data not shown). The
89-kDa protein was no longer present in outer membranes
prepared from FA6930 (Fig. 2, lanes 13 and 14). Transforma-
tion of five additional gonococcal strains, F62, PGH3.2,
FA6940, FA6941, and FA6942, with chromosomal DNA from
FA6930 also resulted in transformants that failed to express
the 89-kDa protein and failed to grow on hemoglobin-Desferal
plates but which could use heme iron (data not shown).
DNA hybridization. In order to confirm that the inability of
FA6930 and FA6929 to utilize hemoglobin was not merely a
reversion of the phenotype, Southern blotting was performed
with two DNA probes. One was an 850-bp hpuB fragment of
the EcoRI digest of the plasmid pSM85k. The other was a
1.1-kb erm fragment of the HindIII-XbaI double digest of
pUC-erm (40). When chromosomal DNA from FA6930 and
FA6929 was digested with ClaI, the hpuB probe hybridized
with a single fragment larger than that from either FA19 Hgb1
or FA1090 Hgb1 (Fig. 3A). However, because of the large
sizes of these fragments, the actual sizes were difficult to de-
termine precisely. The erm probe hybridized with the same
ClaI fragment in the mutants, but no hybridization was de-
tected in FA19 Hgb1 or FA1090 Hgb1 (Fig. 3B). Thus, allelic
replacement was successful in the construction of these two
isogenic mutants. An identical Southern blot was probed with
MS11 hmbR contained in pIRS756 (38). The restriction pat-
tern remained unchanged in mutants, indicating the presence
of an intact hmbR gene in both parents and mutants (data not
shown).
Haptoglobin content in human hemoglobin supply. All
Hgb1 variants grew well on hemoglobin-Desferal plates with-
out added haptoglobin. In order to ensure that the majority of
hemoglobin in our growth plates existed as free hemoglobin
instead of hemoglobin-haptoglobin complexes, the haptoglo-
bin content of the hemoglobin was evaluated by dot blot assay.
By probing immobilized haptoglobin and hemoglobin with an-
ti-human haptoglobin antibodies, it was deduced that the hap-
toglobin content was less than 1% (10 ng/1 mg [Fig. 4]).
Binding of hemoglobin to whole-cell gonococci on dot blot.
To further investigate the role of the 89-kDa protein in the
utilization of hemoglobin, we examined the binding of bioti-
nylated human hemoglobin to immobilized gonococci grown
under iron-sufficient and iron-limited conditions. We were able
to detect biotinylated human hemoglobin binding in iron-
stressed Hgb1 variants of FA19, FA6783, and FA6807 but not
in iron-stressed FA19 Hgb2 or insertional mutants of FA19
Hgb1 and FA1090 Hgb1 (Fig. 5).
Western blot analysis of 89-kDa protein. When the poly-
clonal antibody raised against a peptide from the N terminus of
the 89-kDa protein was used to probe outer membranes pre-
pared from FA19 and its mutants, an 89-kDa protein was
detected in all iron-stressed Hgb1 variants (Fig. 6). In addition
to the 89-kDa band, the antibody reacted with several lower-
molecular-weight bands in all iron-stressed Hgb1 variants.
These extraneous bands were not present in outer membranes
prepared from either the Hgb2 variant of FA19 or the inser-
FIG. 3. Southern blot analysis of insertional mutants, probed with a 850-bp
hpuB fragment from plasmid pSM85k (A) or a 1.1-kb erm fragment. Chromo-
somal DNA from the following strains was digested with ClaI: FA19 Hgb1 (lanes
1), FA6930 (lanes 2), FA1090 Hgb1 (lanes 3), and FA6929 (lanes 4).
FIG. 4. Binding of anti-human haptoglobin antibodies to immobilized hu-
man haptoglobin (blots A and C) and hemoglobin (blots B and D). Blots A and
B were probed with a monoclonal antibody; blots B and D were probed with a
polyclonal antibody. The amount of protein in each well (in micrograms) is
indicated above the blots.
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tional mutant of FA19 Hgb1 (Fig. 6, lanes 2 and 7); thus they
probably represent degradation products of the 89-kDa pro-
tein. In addition, monoclonal antibody A4.85, which reacted
with HpuB (24) and two iron-regulated RTX-like proteins (39)
of N. meningitidis, was used to probe the hemoglobin-bind-
ing protein of N. gonorrhoeae. This antibody recognized an
85-kDa protein in outer membranes prepared from the posi-
tive control, meningococcal FAM69 and reacted weakly with
the 89-kDa proteins of FA19, FA6783, and FA1090 (data not
shown).
Growth with various iron sources. Representative growth
curves of FA19 Hgb2, FA19 Hgb1, and FA6930 in CDM
cultures supplemented with tested iron sources are shown
in Fig. 7. Ferric nitrate was the only source which supported
full growth of both the Hgb1 variants and the hpuB insertional
mutant. FA19 Hgb1 utilized both hemoglobin and hemoglo-
bin-haptoglobin complexes efficiently. In addition, it utilized
haptoglobin to a limited degree (Fig. 7B). Hemoglobin, Hg-Hp
complexes, and haptoglobin also increased the growth of FA19
Hgb2 slightly (Fig. 7A). The mutant, FA6930, showed no sign
of growth with any added iron source other than ferric nitrate
(Fig. 7C).
DISCUSSION
In the present study we report an apparent phase variation
in the utilization of hemoglobin as the sole source of iron by
N. gonorrhoeae. An 89-kDa outer membrane protein was iden-
tified in the hemoglobin-utilizing variants of two strains, FA19
and FA1090, grown under iron-stressed condition. This 89-
kDa protein was affinity purified with hemoglobin immobilized
on agarose as the ligand. Insertional mutants of gonococcal
Hgb1 variants, which no longer expressed the 89-kDa protein,
lost their ability to use hemoglobin as a source of iron. These
mutants also were unable to bind hemoglobin in a whole-cell
dot blot assay. Thus, it is quite likely that the 89-kDa protein is
an iron-regulated receptor for hemoglobin.
While the affinity purification of the 89-kDa protein fol-
lowed the same procedure as that used by Elkins (13) in the
purification of HgbA, the hemoglobin binding protein ofH. du-
creyi, the N-terminal amino acid sequence of the 89-kDa pro-
tein was identical to that of HpuB (24) and different from that
of either HgbA or another hemoglobin receptor of N. menin-
gitidis, HmbR (37, 38). The gene for the gonococcal 89-kDa
protein was readily mutagenized with the meningococcal hpu::
mini-Tn3erm construct, suggesting that the gonococcal gene
was an hpuB homolog.
The hmbR gene encoding the functional HmbR receptor of
N. meningitidis has been found to contain a stop codon in
the N. gonorrhoeae MS11 (38). Southern blot hybridization
of FA19 Hgb1 and FA1090 Hgb1 with MS11 hmbR (38)
demonstrated that these two strains also have the gene encod-
ing HmbR (data not shown). However, in all gonococcal
strains tested, utilization of hemoglobin was abolished in
isogenic mutants which could no longer express the 89-kDa
protein. Thus, while gonococci may have genes for two differ-
ent hemoglobin-binding proteins, the 89-kDa HpuB homo-
log is essential for the utilization of hemoglobin in most gono-
cocci.
The 89-kDa hemoglobin-binding protein is different in mo-
lecular weight from other iron-repressible proteins of N. gon-
orrhoeae, such as hemin-binding proteins (HmBPs, 97 and 44
kDa) (20), FrpB (76 kDa) (2), Tbp 1 (98 to 100 kDa) (8, 22),
or Lbp 1 (100 kDa) (5). Since Hgb1 variants of FA6783 (the
Tf2/Lf2 mutant) and FA6807 (the FrpB2 mutant) both grew
well with hemoglobin as the sole source of iron, it was quite
clear that neither Tbp1, Lbp1, nor FrpB was required for the
utilization of hemoglobin.
In CDM cultures, the FA19 Hgb1 variant grew well with
either hemoglobin or hemoglobin-haptoglobin complexes.
Haptoglobin alone supported minimal growth. Utilization of
haptoglobin for iron-dependent growth has been observed pre-
viously in both meningococci and gonococci (12). We were
unable to identify the source of iron in haptoglobin. Probing
Western blots of haptoglobin with anti-human hemoglobin an-
tibody (Sigma) suggested a hemoglobin content of less than 1
ng/mg of haptoglobin (data not shown). However, since FA19
Hgb1 grew with haptoglobin, the enhanced growth in CDM
culture with hemoglobin-haptoglobin complexes might have
resulted from growth supported by haptoglobin that was not
complexed to hemoglobin instead of a facilitated utilization of
hemoglobin complexed to haptoglobin.
When human hemoglobin was used as the ligand for affinity
purification of gonococcal outer membranes, one 100-kDa
band and one 70-kDa band were recovered in addition to the
89-kDa protein. A 70-kDa protein also appeared in the affinity
purification of meningococcal HpuB protein and gonococcal
hemin-binding proteins (20, 24). The iron-repressible 100-kDa
band was not seen in the purification product of FA6783 and
thus might represent nonspecific binding of Tbp1 and Lbp1.
The 70-kDa band was not iron-regulated, appeared in proteins
recovered from affinity purification of FA6807, and thus could
not be FrpB. The identity and function of this 70 kDa protein
band remain to be determined.
In the absence of a selectable phenotype, we were unable to
demonstrate the predicted switch from an Hgb1 to Hgb2
phase. Nevertheless, the observed ability of gonococci to
switch, at a high frequency of approximately 1023, from an
Hgb2 phase to an Hgb1 phase suggests that the ability to
use hemoglobin is yet another example of phase variation in
FIG. 5. Binding of biotinylated human hemoglobin to iron-replete (A) and
iron-stressed (B) whole cells. Lanes: 1, FA19 Hgb2; 2, FA19 Hgb1; 3, FA6783
Hgb1; 4, FA6807 Hgb1; 5, FA6930; 6, FA6929.
FIG. 6. Expression of 89-kDa protein by Hgb1 variants and insertional mu-
tants. The Western blot was probed with an polyclonal antibody raised against
the N terminus of the 89-kDa protein. The antigen consisted of whole-cell lysates
from 107 gonococci. Lanes: 1, FA19 Hgb2 Fe1; 2, FA19 Hgb2 Fe2; 3, FA19
Hgb1 Fe1; 4, FA19 Hgb1 Fe2; 5, FA6783 Hgb1 Fe2; 6, FA6807 Hgb1 Fe2; 7,
FA6930 Fe2; 8, FA1090 Hgb1 Fe2. Fe1 and Fe2 refer to growth in abundant
iron or in iron starvation, respectively. MW STD, molecular weight standards
(with weights in thousands indicated on the left).
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gonococci. Other phase-varying systems in gonococci include
pilin (16, 28), pilC (18), opacity proteins (26, 36), and lipo-
oligosaccharide (1, 10, 15). While mechanisms underlying
phase variation of these systems are now understood, those
underlying the hemoglobin-binding protein expression have
not yet been studied. It is unclear what advantage might
be produced by the phase variation and the iron repression
of hemoglobin-binding protein expression. We speculate,
however, that phase variation of a hemoglobin-binding pro-
tein in gonococci would enable efficient utilization of men-
strual hemoglobin. Menstrual hemoglobin might be present
in such relative abundance that most is uncomplexed to
haptoglobin. Gonococci might be advantaged by use of free
hemoglobin during that particular phase of the menstrual
cycle.
It is obvious that gonococci possess multiple specific systems
for acquiring iron from the host: transferrin, lactoferrin (5, 6, 9,
27), aerobactin (43), enterobactin (34), hemoglobin (30), and
undoubtedly heme (11, 12, 21). This presumably reflects the
differences in available iron at different body sites and under
different physiological conditions (42), but much remains to be
learned about these systems and their importance.
FIG. 7. Growth of FA19 Hgb1 variant with hemoglobin, haptoglobin, and hemoglobin-haptoglobin complexes and inability of its isogenic mutant to use these iron
sources. Iron-starved gonococci were diluted into CDM plus 50 mM Desferal (E) or into the same medium containing 100 mM Fe(NO3)3 (F [no Desferal]), 0.5 mM
hemoglobin (h), 1.0 mM haptoglobin (Ç), or a 0.5 mM hemoglobin–1.0 mM haptoglobin mixture (■). Similar results were seen in two other experiments.
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